APO Research
Talk to an analyst

APO RESEARCH · REPORT

Biomarkers

In biological system, it means to calculate the whole number by marking part of individuals.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

In biological system, it means to calculate the whole number by marking part of individuals.

Selected research

Market Analysis & Forecast

Global Biomarkers Market Analysis and Forecast 2026-2032

31 December 2025198 pages

Choose your research edition.

Industry ResearchBiomarkers Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Biomarkers Industry Growth and Trends Forecast to 203286 pages · $3,450 USDMarket StructureGlobal Biomarkers Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biomarkers Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Biomarkers Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

In biological system, it means to calculate the whole number by marking part of individuals.

North America is the largest consumption place, with a consumption market share nearly 32% in 2018. Following North America, Europe is the second largest consumption place with the consumption market share of 22.5%.

Report Includes

Read the full market overview

This report presents an overview of global market for Biomarkers, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Biomarkers, also provides the revenue of main regions and countries. Of the upcoming market potential for Biomarkers, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Biomarkers revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Biomarkers market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Biomarkers revenue, projected growth trends, production technology, application and end-user industry.

Biomarkers Segment by Company

Thermo Fisher Scientific

Merck

Bio-Rad Laboratories

QIAGEN

Roche

Danaher Corporation

Siemens Healthcare

Abbott

Agilent Technologies

Biomarkers Segment by Type

Sepsis Biomarkers

Antibiotic Resistance Biomarkers

Traumatic Brain Injury (TBI) Testing Biomarkers

Stroke Testing Biomarkers

Antibiotic Stewardship Biomarkers

Other

Biomarkers Segment by Application

Diagnostics

Drug Discovery

Personalized Medicine

Other

Biomarkers Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biomarkers market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biomarkers and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biomarkers.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Biomarkers in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Biomarkers company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biomarkers revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Biomarkers Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Sepsis Biomarkers Major Player Table 3. Antibiotic Resistance Biomarkers Major Player Table 4. Traumatic Brain Injury (TBI) Testing Biomarkers Major Player Table 5. Stroke Testing Biomarkers Major Player Table 6. Antibiotic Stewardship Biomarkers Major Player Table 7. Other Major Player Table 8. Global Biomarkers Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 9. Diagnostics Major Player Table 10. Drug Discovery Major Player Table 11. Personalized Medicine Major Player Table 12. Other Major Player Table 13. Biomarkers Industry Trends Table 14. Biomarkers Industry Drivers Table 15. Biomarkers Industry Opportunities and Challenges Table 16. Biomarkers Industry Restraints Table 17. Global Biomarkers Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 18. Global Biomarkers Market Size by Region (2021-2026) & (US$ Million) Table 19. Global Biomarkers Market Share by Region (2021-2026) Table 20. Global Biomarkers Market Size by Region (2027-2032) & (US$ Million) Table 21. Global Biomarkers Market Share by Region (2027-2032) Table 22. Global Biomarkers Revenue by Players (US$ Million) & (2021-2026) Table 23. Global Biomarkers Revenue Market Share by Players (2021-2026) Table 24. Global Biomarkers Key Players Ranking, 2024 VS 2025 VS 2026 Table 25. Global Biomarkers Key Players Headquarters & Area Served Table 26. Global Biomarkers Players, Product Type & Application Table 27. Global Biomarkers Players Establishment Date Table 28. Global Players Market Concentration Ratio (CR5 and HHI) Table 29. Global Biomarkers by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 30. Global Biomarkers Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Biomarkers Revenue by Type (2021-2026) & (US$ Million) Table 32. Global Biomarkers Revenue by Type (2027-2032) & (US$ Million) Table 33. Global Biomarkers Revenue Market Share by Type (2021-2026) Table 34. Global Biomarkers Revenue Market Share by Type (2027-2032) Table 35. Global Biomarkers Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Biomarkers Revenue by Application (2021-2026) & (US$ Million) Table 37. Global Biomarkers Revenue by Application (2027-2032) & (US$ Million) Table 38. Global Biomarkers Revenue Market Share by Application (2021-2026) Table 39. Global Biomarkers Revenue Market Share by Application (2027-2032) Table 40. Thermo Fisher Scientific Company Information Table 41. Thermo Fisher Scientific Business Overview Table 42. Thermo Fisher Scientific Biomarkers Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Thermo Fisher Scientific Biomarkers Product Portfolio Table 44. Thermo Fisher Scientific Recent Development Table 45. Merck Company Information Table 46. Merck Business Overview Table 47. Merck Biomarkers Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Merck Biomarkers Product Portfolio Table 49. Merck Recent Development Table 50. Bio-Rad Laboratories Company Information Table 51. Bio-Rad Laboratories Business Overview Table 52. Bio-Rad Laboratories Biomarkers Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Bio-Rad Laboratories Biomarkers Product Portfolio Table 54. Bio-Rad Laboratories Recent Development Table 55. QIAGEN Company Information Table 56. QIAGEN Business Overview Table 57. QIAGEN Biomarkers Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. QIAGEN Biomarkers Product Portfolio Table 59. QIAGEN Recent Development Table 60. Roche Company Information Table 61. Roche Business Overview Table 62. Roche Biomarkers Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Roche Biomarkers Product Portfolio Table 64. Roche Recent Development Table 65. Danaher Corporation Company Information Table 66. Danaher Corporation Business Overview Table 67. Danaher Corporation Biomarkers Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Danaher Corporation Biomarkers Product Portfolio Table 69. Danaher Corporation Recent Development Table 70. Siemens Healthcare Company Information Table 71. Siemens Healthcare Business Overview Table 72. Siemens Healthcare Biomarkers Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Siemens Healthcare Biomarkers Product Portfolio Table 74. Siemens Healthcare Recent Development Table 75. Abbott Company Information Table 76. Abbott Business Overview Table 77. Abbott Biomarkers Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Abbott Biomarkers Product Portfolio Table 79. Abbott Recent Development Table 80. Agilent Technologies Company Information Table 81. Agilent Technologies Business Overview Table 82. Agilent Technologies Biomarkers Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Agilent Technologies Biomarkers Product Portfolio Table 84. Agilent Technologies Recent Development Table 85. North America Biomarkers Revenue by Type (2021-2026) & (US$ Million) Table 86. North America Biomarkers Revenue by Type (2027-2032) & (US$ Million) Table 87. North America Biomarkers Revenue by Application (2021-2026) & (US$ Million) Table 88. North America Biomarkers Revenue by Application (2027-2032) & (US$ Million) Table 89. North America Biomarkers Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 90. North America Biomarkers Revenue by Country (2021-2026) & (US$ Million) Table 91. North America Biomarkers Revenue by Country (US$ Million) & (2027-2032) Table 92. Europe Biomarkers Revenue by Type (2021-2026) & (US$ Million) Table 93. Europe Biomarkers Revenue by Type (2027-2032) & (US$ Million) Table 94. Europe Biomarkers Revenue by Application (2021-2026) & (US$ Million) Table 95. Europe Biomarkers Revenue by Application (2027-2032) & (US$ Million) Table 96. Europe Biomarkers Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 97. Europe Biomarkers Revenue by Country (2021-2026) & (US$ Million) Table 98. Europe Biomarkers Revenue by Country (US$ Million) & (2027-2032) Table 99. China Biomarkers Revenue by Type (2021-2026) & (US$ Million) Table 100. China Biomarkers Revenue by Type (2027-2032) & (US$ Million) Table 101. China Biomarkers Revenue by Application (2021-2026) & (US$ Million) Table 102. China Biomarkers Revenue by Application (2027-2032) & (US$ Million) Table 103. Asia Biomarkers Revenue by Type (2021-2026) & (US$ Million) Table 104. Asia Biomarkers Revenue by Type (2027-2032) & (US$ Million) Table 105. Asia Biomarkers Revenue by Application (2021-2026) & (US$ Million) Table 106. Asia Biomarkers Revenue by Application (2027-2032) & (US$ Million) Table 107. Asia Biomarkers Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 108. Asia Biomarkers Revenue by Region (US$ Million) & (2021-2026) Table 109. Asia Biomarkers Revenue by Region (US$ Million) & (2027-2032) Table 110. SAMEA Biomarkers Revenue by Type (2021-2026) & (US$ Million) Table 111. SAMEA Biomarkers Revenue by Type (2027-2032) & (US$ Million) Table 112. SAMEA Biomarkers Revenue by Application (2021-2026) & (US$ Million) Table 113. SAMEA Biomarkers Revenue by Application (2027-2032) & (US$ Million) Table 114. SAMEA Biomarkers Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 115. SAMEA Biomarkers Revenue by Country (2021-2026) & (US$ Million) Table 116. SAMEA Biomarkers Revenue by Country (US$ Million) & (2027-2032) Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. Biomarkers Image Figure 2. Global Biomarkers Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Biomarkers Market Size Share 2021 VS 2025 VS 2032 Figure 4. Sepsis Biomarkers Image Figure 5. Antibiotic Resistance Biomarkers Image Figure 6. Traumatic Brain Injury (TBI) Testing Biomarkers Image Figure 7. Stroke Testing Biomarkers Image Figure 8. Antibiotic Stewardship Biomarkers Image Figure 9. Other Image Figure 10. Global Biomarkers Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Biomarkers Market Size Share 2021 VS 2025 VS 2032 Figure 12. Diagnostics Image Figure 13. Drug Discovery Image Figure 14. Personalized Medicine Image Figure 15. Other Image Figure 16. Global Biomarkers Market Size (US$ Million) & (2021-2032) Figure 17. Global Biomarkers Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 18. Global Biomarkers Market Share by Region: 2021 VS 2025 VS 2032 Figure 19. Global Biomarkers Players Revenue Share Top 10 and Top 5 in 2025 Figure 20. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Biomarkers Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Biomarkers Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Biomarkers Revenue Market Share by Type (2021-2032) Figure 24. Global Biomarkers Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Biomarkers Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 26. Global Biomarkers Revenue Market Share by Application (2021-2032) Figure 27. North America Biomarkers Revenue YoY Growth (2021-2032) & (US$ Million) Figure 28. North America Biomarkers Revenue Share by Type (2021-2032) Figure 29. North America Biomarkers Revenue Share by Application (2021-2032) Figure 30. North America Biomarkers Revenue Share by Country (2021-2032) Figure 31. United States Biomarkers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Canada Biomarkers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. Mexico Biomarkers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. Europe Biomarkers Revenue YoY Growth (2021-2032) & (US$ Million) Figure 35. Europe Biomarkers Revenue Share by Type (2021-2032) Figure 36. Europe Biomarkers Revenue Share by Application (2021-2032) Figure 37. Europe Biomarkers Revenue Share by Country (2021-2032) Figure 38. Germany Biomarkers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. France Biomarkers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. U.K. Biomarkers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Italy Biomarkers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Spain Biomarkers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Russia Biomarkers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Netherlands Biomarkers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. Nordic Countries Biomarkers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 46. China Biomarkers Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. China Biomarkers Revenue Share by Type (2021-2032) Figure 48. China Biomarkers Revenue Share by Application (2021-2032) Figure 49. Asia Biomarkers Revenue YoY Growth (2021-2032) & (US$ Million) Figure 50. Asia Biomarkers Revenue Share by Type (2021-2032) Figure 51. Asia Biomarkers Revenue Share by Application (2021-2032) Figure 52. Asia Biomarkers Revenue Share by Region (2021-2032) Figure 53. Japan Biomarkers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. South Korea Biomarkers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. India Biomarkers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Australia Biomarkers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. Taiwan Biomarkers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Southeast Asia Biomarkers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. SAMEA Biomarkers Revenue YoY Growth (2021-2032) & (US$ Million) Figure 60. SAMEA Biomarkers Revenue Share by Type (2021-2032) Figure 61. SAMEA Biomarkers Revenue Share by Application (2021-2032) Figure 62. SAMEA Biomarkers Revenue Share by Country (2021-2032) Figure 63. Brazil Biomarkers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Argentina Biomarkers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Chile Biomarkers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Colombia Biomarkers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Peru Biomarkers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Saudi Arabia Biomarkers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Israel Biomarkers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. UAE Biomarkers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Turkey Biomarkers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Iran Biomarkers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Egypt Biomarkers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Sepsis Biomarkers
  • Antibiotic Resistance Biomarkers
  • Traumatic Brain Injury (TBI) Testing Biomarkers
  • Stroke Testing Biomarkers
  • Antibiotic Stewardship Biomarkers
  • Other
Applications
  • Diagnostics
  • Drug Discovery
  • Personalized Medicine
  • Other
Companies covered
  • Thermo Fisher Scientific
  • Merck
  • Bio-Rad Laboratories
  • QIAGEN
  • Roche
  • Danaher Corporation
  • Siemens Healthcare
  • Abbott
  • Agilent Technologies

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Biomarkers Market by Type
  3. 1.2.1 Global Biomarkers Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Sepsis Biomarkers
  5. 1.2.3 Antibiotic Resistance Biomarkers
  6. 1.2.4 Traumatic Brain Injury (TBI) Testing Biomarkers
  7. 1.2.5 Stroke Testing Biomarkers
  8. 1.2.6 Antibiotic Stewardship Biomarkers
  9. 1.2.7 Other
  10. 1.3 Biomarkers Market by Application
  11. 1.3.1 Global Biomarkers Market Size by Application, 2021 VS 2025 VS 2032
  12. 1.3.2 Diagnostics
  13. 1.3.3 Drug Discovery
  14. 1.3.4 Personalized Medicine
  15. 1.3.5 Other
  16. 1.4 Assumptions and Limitations
  17. 1.5 Study Goals and Objectives
2 Biomarkers Market Dynamics
  1. 2.1 Biomarkers Industry Trends
  2. 2.2 Biomarkers Industry Drivers
  3. 2.3 Biomarkers Industry Opportunities and Challenges
  4. 2.4 Biomarkers Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Biomarkers Market Perspective (2021-2032)
  2. 3.2 Global Biomarkers Growth Trends by Region
  3. 3.2.1 Global Biomarkers Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Biomarkers Market Size by Region (2021-2026)
  5. 3.2.3 Global Biomarkers Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Biomarkers Revenue by Players
  2. 4.1.1 Global Biomarkers Revenue by Players (2021-2026)
  3. 4.1.2 Global Biomarkers Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Biomarkers Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Biomarkers Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Biomarkers Key Players Headquarters & Area Served
  7. 4.4 Global Biomarkers Players, Product Type & Application
  8. 4.5 Global Biomarkers Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Biomarkers Market CR5 and HHI
  11. 4.6.3 2025 Biomarkers Tier 1, Tier 2, and Tier 3
5 Biomarkers Market Size by Type
  1. 5.1 Global Biomarkers Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Biomarkers Revenue by Type (2021-2032)
  3. 5.3 Global Biomarkers Revenue Market Share by Type (2021-2032)
6 Biomarkers Market Size by Application
  1. 6.1 Global Biomarkers Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Biomarkers Revenue by Application (2021-2032)
  3. 6.3 Global Biomarkers Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Thermo Fisher Scientific
  2. 7.1.1 Thermo Fisher Scientific Company Information
  3. 7.1.2 Thermo Fisher Scientific Business Overview
  4. 7.1.3 Thermo Fisher Scientific Biomarkers Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Thermo Fisher Scientific Biomarkers Product Portfolio
  6. 7.1.5 Thermo Fisher Scientific Recent Developments
  7. 7.2 Merck
  8. 7.2.1 Merck Company Information
  9. 7.2.2 Merck Business Overview
  10. 7.2.3 Merck Biomarkers Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Merck Biomarkers Product Portfolio
  12. 7.2.5 Merck Recent Developments
  13. 7.3 Bio-Rad Laboratories
  14. 7.3.1 Bio-Rad Laboratories Company Information
  15. 7.3.2 Bio-Rad Laboratories Business Overview
  16. 7.3.3 Bio-Rad Laboratories Biomarkers Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Bio-Rad Laboratories Biomarkers Product Portfolio
  18. 7.3.5 Bio-Rad Laboratories Recent Developments
  19. 7.4 QIAGEN
  20. 7.4.1 QIAGEN Company Information
  21. 7.4.2 QIAGEN Business Overview
  22. 7.4.3 QIAGEN Biomarkers Revenue and Gross Margin (2021-2026)
  23. 7.4.4 QIAGEN Biomarkers Product Portfolio
  24. 7.4.5 QIAGEN Recent Developments
  25. 7.5 Roche
  26. 7.5.1 Roche Company Information
  27. 7.5.2 Roche Business Overview
  28. 7.5.3 Roche Biomarkers Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Roche Biomarkers Product Portfolio
  30. 7.5.5 Roche Recent Developments
  31. 7.6 Danaher Corporation
  32. 7.6.1 Danaher Corporation Company Information
  33. 7.6.2 Danaher Corporation Business Overview
  34. 7.6.3 Danaher Corporation Biomarkers Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Danaher Corporation Biomarkers Product Portfolio
  36. 7.6.5 Danaher Corporation Recent Developments
  37. 7.7 Siemens Healthcare
  38. 7.7.1 Siemens Healthcare Company Information
  39. 7.7.2 Siemens Healthcare Business Overview
  40. 7.7.3 Siemens Healthcare Biomarkers Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Siemens Healthcare Biomarkers Product Portfolio
  42. 7.7.5 Siemens Healthcare Recent Developments
  43. 7.8 Abbott
  44. 7.8.1 Abbott Company Information
  45. 7.8.2 Abbott Business Overview
  46. 7.8.3 Abbott Biomarkers Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Abbott Biomarkers Product Portfolio
  48. 7.8.5 Abbott Recent Developments
  49. 7.9 Agilent Technologies
  50. 7.9.1 Agilent Technologies Company Information
  51. 7.9.2 Agilent Technologies Business Overview
  52. 7.9.3 Agilent Technologies Biomarkers Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Agilent Technologies Biomarkers Product Portfolio
  54. 7.9.5 Agilent Technologies Recent Developments
8 North America
  1. 8.1 North America Biomarkers Revenue (2021-2032)
  2. 8.2 North America Biomarkers Revenue by Type (2021-2032)
  3. 8.2.1 North America Biomarkers Revenue by Type (2021-2026)
  4. 8.2.2 North America Biomarkers Revenue by Type (2027-2032)
  5. 8.3 North America Biomarkers Revenue Share by Type (2021-2032)
  6. 8.4 North America Biomarkers Revenue by Application (2021-2032)
  7. 8.4.1 North America Biomarkers Revenue by Application (2021-2026)
  8. 8.4.2 North America Biomarkers Revenue by Application (2027-2032)
  9. 8.5 North America Biomarkers Revenue Share by Application (2021-2032)
  10. 8.6 North America Biomarkers Revenue by Country
  11. 8.6.1 North America Biomarkers Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Biomarkers Revenue by Country (2021-2026)
  13. 8.6.3 North America Biomarkers Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Biomarkers Revenue (2021-2032)
  2. 9.2 Europe Biomarkers Revenue by Type (2021-2032)
  3. 9.2.1 Europe Biomarkers Revenue by Type (2021-2026)
  4. 9.2.2 Europe Biomarkers Revenue by Type (2027-2032)
  5. 9.3 Europe Biomarkers Revenue Share by Type (2021-2032)
  6. 9.4 Europe Biomarkers Revenue by Application (2021-2032)
  7. 9.4.1 Europe Biomarkers Revenue by Application (2021-2026)
  8. 9.4.2 Europe Biomarkers Revenue by Application (2027-2032)
  9. 9.5 Europe Biomarkers Revenue Share by Application (2021-2032)
  10. 9.6 Europe Biomarkers Revenue by Country
  11. 9.6.1 Europe Biomarkers Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Biomarkers Revenue by Country (2021-2026)
  13. 9.6.3 Europe Biomarkers Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Biomarkers Revenue (2021-2032)
  2. 10.2 China Biomarkers Revenue by Type (2021-2032)
  3. 10.2.1 China Biomarkers Revenue by Type (2021-2026)
  4. 10.2.2 China Biomarkers Revenue by Type (2027-2032)
  5. 10.3 China Biomarkers Revenue Share by Type (2021-2032)
  6. 10.4 China Biomarkers Revenue by Application (2021-2032)
  7. 10.4.1 China Biomarkers Revenue by Application (2021-2026)
  8. 10.4.2 China Biomarkers Revenue by Application (2027-2032)
  9. 10.5 China Biomarkers Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Biomarkers Revenue (2021-2032)
  2. 11.2 Asia Biomarkers Revenue by Type (2021-2032)
  3. 11.2.1 Asia Biomarkers Revenue by Type (2021-2026)
  4. 11.2.2 Asia Biomarkers Revenue by Type (2027-2032)
  5. 11.3 Asia Biomarkers Revenue Share by Type (2021-2032)
  6. 11.4 Asia Biomarkers Revenue by Application (2021-2032)
  7. 11.4.1 Asia Biomarkers Revenue by Application (2021-2026)
  8. 11.4.2 Asia Biomarkers Revenue by Application (2027-2032)
  9. 11.5 Asia Biomarkers Revenue Share by Application (2021-2032)
  10. 11.6 Asia Biomarkers Revenue by Country
  11. 11.6.1 Asia Biomarkers Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Biomarkers Revenue by Country (2021-2026)
  13. 11.6.3 Asia Biomarkers Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Biomarkers Revenue (2021-2032)
  2. 12.2 SAMEA Biomarkers Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Biomarkers Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Biomarkers Revenue by Type (2027-2032)
  5. 12.3 SAMEA Biomarkers Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Biomarkers Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Biomarkers Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Biomarkers Revenue by Application (2027-2032)
  9. 12.5 SAMEA Biomarkers Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Biomarkers Revenue by Country
  11. 12.6.1 SAMEA Biomarkers Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Biomarkers Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Biomarkers Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst